toluene 2,4-diisocyanate has been researched along with Disease Models, Animal in 111 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (9.01) | 18.7374 |
1990's | 18 (16.22) | 18.2507 |
2000's | 35 (31.53) | 29.6817 |
2010's | 36 (32.43) | 24.3611 |
2020's | 12 (10.81) | 2.80 |
Authors | Studies |
---|---|
Cai, S; Dong, H; Huang, M; Lan, Z; Li, B; Liu, L; Peng, X; Wang, X; Yu, C; Yuan, Y; Zhao, H; Zhao, W | 1 |
Cai, S; Chen, X; Chen, Y; Gong, Z; Huang, J; Li, Y; Peng, X; Wang, Y; Yang, S; Yu, C; Zhao, H; Zhao, W | 1 |
Cui, H; He, J; He, Y; Luo, G; Sun, E; Yang, F; Zhai, Z; Zhao, H; Zhao, W; Zhuang, J; Zhuang, L | 1 |
Bazzan, E; Blomme, EE; Bonato, M; Bontinck, A; Brusselle, GG; Cosio, MG; Joos, GF; Maes, T; Pollaris, L; Provoost, S; Roffel, MP; Saetta, M; Van Eeckhoutte, HP; Vandenbroucke, L; Vanoirbeek, JAJ; Verhamme, F | 1 |
Li, J; Shi, J; Song, J; Xu, C; Yao, L | 1 |
Fukuyama, T; Kurata, K; Tajiki-Nishino, R; Tajima, H; Watanabe, Y | 1 |
Aihara, R; Fukuyama, T; Iwashita, N; Kushiro, M; Miyake, S; Miyasaka, A; Morimoto, A; Ookawara, T; Takagi, Y | 1 |
Cai, S; Cheng, W; Cheng, Y; Cui, H; Dong, J; He, Y; Wang, L; Zhao, H; Zhao, W; Zhou, FH | 1 |
Cai, S; Deng, Z; Dong, H; Huang, G; Su, J; Wang, P; Zhao, H; Zhao, W | 1 |
Chen, R; Chen, S; Deng, Y; Huang, Y; Song, S; Tao, A | 1 |
Chang, P; Chen, S; Chen, X; Deng, Y; Li, J; Song, J; Tang, H; Xu, C; Yao, L | 1 |
Chen, R; Chen, S; Chen, Z; Deng, Y; Li, D; Liang, Z; Liu, S; Yang, K; Yu, L; Zha, S | 1 |
Cai, S; Dong, H; Le, Y; Lin, Y; Wang, Y; Wu, Y; Xiong, J; Yu, C; Zhao, H; Zhao, W; Zou, F | 1 |
Ceuppens, J; Cremer, J; Devos, FC; Hoet, PHM; Hoshino, T; Nemery, B; Pollaris, L; Seys, S; Talavera, K; Vanoirbeek, JAJ | 1 |
Choi, WS; Choi, Y; Hong, KH; Kim, JH; Lee, WY; Park, C; Park, HJ; Song, H | 1 |
Cai, S; Dong, H; Huang, G; Lin, Y; Xiao, G; Xiong, J; Yao, L; Yu, C; Zhao, H; Zhao, W | 1 |
Fukuyama, T; Ishimota, M; Makino, E; Tajiki-Nishino, R; Tajima, H; Watanabe, Y | 1 |
Lim, JCW; Mohtarrudin, N; Stanslas, J; Sulaiman, I; Tan, K | 1 |
Cai, S; Deng, Q; Dong, H; Huang, G; Lin, Y; Wang, Y; Xiong, J; Yao, L; Yu, C; Zhao, H; Zhao, W | 1 |
Chen, R; Chen, S; Chen, X; Huang, P; Liang, Z; Tang, H; Tao, A; Wei, S; Yao, L; Zhang, Q | 1 |
Chen, R; Chen, S; Guan, H; He, Q; Huang, P; Luo, Y; Peng, G; Tao, A; Wei, S; Yan, J; Yao, L; Zhang, Q; Zou, Z | 1 |
Cremer, J; Decaesteker, T; Devos, FC; Hoet, PHM; Maes, T; Nemery, B; Pollaris, L; Provoost, S; Seys, S; Van Den Broucke, S; Vande Velde, G; Vanoirbeek, JAJ; Verbeken, E | 1 |
Cai, S; Dong, H; Liang, Z; Liu, L; Lv, Y; Song, J; Tang, H; Zhang, D; Zhao, H; Zou, F; Zou, M | 1 |
Li, W; Liu, F; Pauluhn, J; Trübel, H; Wang, C | 1 |
Carlier, V; De Vooght, V; Devos, FC; Haenen, S; Hoet, PH; Nemery, B; Vanoirbeek, JA; Verbeken, E | 1 |
Cai, S; Dong, H; Liang, Z; LV, Y; Song, J; Tang, H; Yao, L; Zhao, H; Zou, F | 1 |
Cai, S; Dong, H; Liang, J; Liu, L; Tang, H; Wu, Y; Yao, L; Zhao, H; Zou, F | 1 |
Bokhari, J; Khan, MR | 1 |
Bäumer, W; Fukuyama, T; Qi, Y; Tschernig, T; Volmer, DA | 1 |
Cai, S; Dong, H; Song, J; Tang, H; Yao, L; Zhao, H; Zou, F | 1 |
De Vooght, V; Devos, F; Hoet, PH; Nemery, B; Pollaris, L; Seys, S; Vanoirbeek, JA | 1 |
Fukui, H; Kadota, T; Karmakar, S; Kashiwada, Y; Kitamura, Y; Mizuguchi, H; Mukherjee, PK; Nemoto, H; Shill, MC; Takeda, N | 1 |
Anderson, SE; Kashon, ML; Long, CM; Lukomska, E; Marshall, NB; Meade, BJ; Shane, H | 1 |
Bäumer, W; Dunston, SM; Ehling, S; Roßbach, K; Stark, H | 1 |
Cai, S; Dong, H; Liang, J; Liu, L; Tang, H; Yao, L; Zhao, H; Zou, F | 1 |
Cai, S; Dong, H; Liu, L; Tang, H; Xiong, J; Yao, L; Zhao, H; Zhao, W; Zou, F | 1 |
Cao, M; Gao, N; Gong, Y; Hu, CP; Huang, JB; Li, GB; Tang, Q; Wang, QH; Xing, M; Xiong, Y; Zhang, Q; Zhang, R | 1 |
Bäumer, W; Crapo, JD; Daniele, MA; Fukuyama, T; Oberley, R; Stover, K; Young, AT | 1 |
Fukuyama, T; Harada, T; Hayashi, K; Kosaka, T; Saito, TR; Shuto, Y; Tajima, Y; Ueda, H | 2 |
Jabłońska, E; Kur, B; Polakowska, E; Tarkowski, M | 1 |
Das, AK; Dev, S; Fukui, H; Kitamura, Y; Kodama, M; Matsushita, C; Mizuguchi, H; Takeda, N; Umehara, H | 1 |
De Vooght, V; Hoet, PH; Nemery, B; Synhaeve, N; Vanoirbeek, JA | 1 |
De Vooght, V; Haenen, S; Hoet, PH; Nemery, B; Vanoirbeek, JA; Verbeken, E | 2 |
Kimoto, N; Tamura, T | 1 |
Bäumer, W; Jennings, G; Rundfeldt, C; Wlaź, P | 1 |
Boland, S; De Vooght, V; Dinsdale, D; Hoet, PH; Hussain, S; Luyts, K; Marano, F; Martens, JA; Nemery, B; Thomassen, LC; Vanoirbeek, JA; Verbeken, E | 1 |
Clynen, E; De Vooght, V; Haenen, S; Hoet, PH; Maes, E; Nemery, B; Schoofs, L; Vanoirbeek, JA | 1 |
Baba, Y; Das, AK; Dev, S; Fukui, H; Mizuguchi, H | 1 |
Choudhuri, MS; Fukui, H; Hattori, M; Maeyama, K; Mizuguchi, H; Mukherjee, PK; Nurul, IM; Shahriar, M; Takeda, N; Venkatesh, P | 1 |
Chae, HJ; Jeon, MS; Kim, DI; Kim, SR; Lee, KS; Lee, YC; Park, SJ; Yoo, WH | 1 |
Pałczyński, C; Swierczyńska-Machura, D | 1 |
Nowakowska-Świrta, E; Pałczyński, C; Piasecka-Zelga, J; Świercz, R; Świerczyńska-Machura, D; Walusiak-Skorupa, J | 1 |
Baba, Y; Fukui, H; Hattori, M; Kitamura, Y; Kobayashi, M; Mizuguchi, H; Nakano, T; Ono, S; Sasaki, Y; Takeda, N; Zhang, Q | 1 |
Gordon, T; Redlich, CA; Wisnewski, AV | 1 |
Collins, MA | 1 |
Colmsjö, A; Johansson, R; Karlsson, D; Låstbom, L; Melin, J; Nordqvist, Y; Skarping, G | 1 |
Han, D; Zhang, F; Zhu, X | 1 |
Gu, H; Hayashi, S; Iimura, A; Itoh, M; Matsuyama, N; Miki, T; Nakamura, Y; Takeuchi, Y | 1 |
Ceuppens, JL; Hoet, PH; Nemery, B; Tarkowski, M; Vanoirbeek, JA; Verbeken, EK | 1 |
Jin, SM; Kim, SS; Lee, KS; Lee, YC | 1 |
Bloksma, N; Henricks, PA; Nijkamp, FP; Schijf, MA; Valstar, DL | 1 |
Fukui, H; Kalubi, B; Kitamura, Y; Miyoshi, A; Murata, Y; Takeda, N | 1 |
Imoto, K; Koda, A; Kohno, S; Nabe, T; Niwa, T; Shinjo, Y; Yamauchi, K | 1 |
Ariizumi, M; Kouadio, K; Todoriki, H; Tuekpe, MK; Zheng, KC | 1 |
Johnson, VJ; Luster, MI; Yucesoy, B | 1 |
Ban, M; Binet, S; Huguet, N; Langonné, I; Morel, G; Pépin, E | 1 |
Choi, IW; Kim, SH; Lee, CM; Lee, HK; Moon, DO; Park, HJ; Park, YM; Roh, HJ | 1 |
Alejandra Hossen, M; Fujii, Y; Kamei, C; Kishi, Y; Tsumuro, T | 1 |
Ceuppens, J; De Vooght, V; Hoet, PH; Mercier, CM; Nemery, B; Tarkowski, M; Vanhooren, HM; Vanoirbeek, JA | 1 |
Jin, SM; Kim, SR; Lee, HK; Lee, KS; Lee, YC; Min, KH; Park, SJ | 1 |
Aardal, NP; Aasen, TB; Bronstad, AM; Elsayed, S; Irgens, A; Sun, LZ; Van Do, T | 1 |
Fluharty, K; Johnson, VJ; Luster, MI; Reynolds, JS; Richardson, D; Wang, W; Yucesoy, B | 1 |
Arredouani, MS; Fedulov, A; Hubeau, C; Kobzik, L; Lim, RH | 1 |
Choe, YH; Hong, SJ; Kim, JS; Kim, SR; Lee, KS; Lee, KY; Lee, YC; Lee, YR; Min, KH; Park, SJ | 1 |
Fukui, H | 1 |
Komai, M; Tamura, T | 1 |
Ino, T; Kawai, M; Maekawa, N; Ohata, K; Okamoto, Y; Takeoka, A; Tanaka, K; Watanabe-Kohno, S | 1 |
Bernstein, IL; Chen, SE | 1 |
Bernstein, IL; Chen, SE; Splansky, GL; Vinegar, A | 1 |
Kawai, M; Maekawa, N; Tanaka, K | 2 |
Karol, MH; Kramarik, JA; Satoh, T; Tollerud, DJ | 1 |
Ikeda, H; Kitajiri, M; Kubo, N; Kumazawa, T; Sato, K | 1 |
Okamoto, Y; Sawahata, T; Sugawara, Y; Tanaka, K | 1 |
Aoyama, K; Huang, J; Ueda, A | 1 |
Blaikie, L; Botham, PA; Hartop, PJ; Hext, P; Morrow, T; Rattray, NJ; Wilson, AP; Woodcock, D | 1 |
Amitani, R; Kawai, M; Kuze, F; Niimi, A; Tanaka, K; Yamada, K | 1 |
Okamoto, Y; Sawahate, T; Sugawara, Y; Tanaka, K | 1 |
Zhao, XJ | 1 |
Baur, X; Marczynski, B; Marek, W; Potthast, J | 1 |
Baur, X; Marcynski, B; Marek, W; Potthast, JJ | 1 |
Pauluhn, J | 1 |
Chitano, P; Fabbri, LM; Jovine, L; Lucchini, RE; Maestrelli, P; Mapp, CE; Miotto, D; Polak, J; Saetta, M; Springall, DR | 1 |
Baur, X; Marczynski, B; Marek, W; Mensing, T; Potthast, J | 1 |
Adjei, AA; Ariizumi, M; Shinjo, M; Shinjo, S; Todoriki, H; Zheng, K | 1 |
Ehinger, AM; Ehinger, B; Gorr, G; Hoppmann, J; Kietzmann, M; Telser, E | 1 |
Boschetto, P; Cassetti, P; De Marzo, N; Jovine, L; Maestrelli, P; Mapp, CE; Miotto, D; Rizzotti, P; Saetta, M | 1 |
Karol, MH; Lange, RW; Lemus, R; Luster, MI; Matheson, JM | 1 |
Koh, GY; Lee, HB; Lee, YC; Oh, JL; Park, HS; Rhee, YK; Song, CH | 1 |
Ariizumi, M; Morioka, T; Nong, DX; Todoriki, H; Zheng, KC | 1 |
Kwak, YG; Lee, YC; Song, CH | 1 |
Karol, MH | 1 |
Liu, JY | 1 |
Borm, PJ; Henderson, PT; Jorna, TH | 1 |
Hanada, S; Nishimura, F; Takeoka, A; Tanaka, K | 1 |
Hanada, S; Kawai, M; Kohno, S; Nagaya, Y; Nishimura, F; Okamoto, Y; Takeoka, A; Tanaka, K | 1 |
Karol, MH; Magreni, C; Stadler, J | 1 |
Hanada, S; Ino, T; Kohno, S; Okamoto, Y; Okuizumi, J; Takeoka, A; Tanaka, K | 1 |
5 review(s) available for toluene 2,4-diisocyanate and Disease Models, Animal
Article | Year |
---|---|
[Pathogenetic and clinical aspects of diisocyanate asthma].
Topics: Air Pollutants, Occupational; Animals; Asthma; Bronchial Hyperreactivity; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Models, Animal; Humans; Immunoglobulin E; Mice; Occupational Diseases; Occupational Exposure; T-Lymphocytes; Toluene 2,4-Diisocyanate | 2012 |
Mouse models of diisocyanate asthma.
Topics: Allergens; Animals; Asthma; Cyanates; Disease Models, Animal; Isocyanates; Mice; Models, Biological; Models, Chemical; Toluene 2,4-Diisocyanate | 2002 |
Toxicology of toluene diisocyanate.
Topics: Administration, Inhalation; Administration, Oral; Air Pollutants, Occupational; Animals; Carcinogens; Disease Models, Animal; Female; Guinea Pigs; Humans; Irritants; Lethal Dose 50; Male; Mice; Rats; Rats, Inbred F344; Toluene 2,4-Diisocyanate | 2002 |
Setting acceptable exposure limits for toluene diisocyanate on the basis of different airway effects observed in animals.
Topics: Administration, Inhalation; Animals; Disease Models, Animal; Guinea Pigs; Humans; Maximum Allowable Concentration; Meta-Analysis as Topic; Mice; Occupational Exposure; Respiration Disorders; Toluene 2,4-Diisocyanate | 1990 |
Immunotoxicologic evaluation of the respiratory system: animal models for immediate- and delayed-onset pulmonary hypersensitivity.
Topics: Animals; Bronchi; Disease Models, Animal; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Lung; Lung Diseases; Occupational Diseases; Skin Tests; Subtilisins; Time Factors; Toluene 2,4-Diisocyanate | 1985 |
106 other study(ies) available for toluene 2,4-diisocyanate and Disease Models, Animal
Article | Year |
---|---|
RAGE mediates airway inflammation via the HDAC1 pathway in a toluene diisocyanate-induced murine asthma model.
Topics: Animals; Asthma; Benzamides; Cell Line; Cytokines; Depsipeptides; Disease Models, Animal; Histone Deacetylase 1; Humans; Inflammation; Male; Mice; Mice, Inbred BALB C; Phosphatidylinositol 3-Kinases; Receptor for Advanced Glycation End Products; Signal Transduction; Toluene 2,4-Diisocyanate | 2022 |
Blockade of neutrophil extracellular traps ameliorates toluene diisocyanate-induced steroid-resistant asthma.
Topics: Animals; Asthma; Dexamethasone; Disease Models, Animal; Extracellular Traps; Humans; Inflammation; Interleukin-8; Mice; Steroids; Toluene 2,4-Diisocyanate | 2023 |
Bronchial epithelial pyroptosis promotes airway inflammation in a murine model of toluene diisocyanate-induced asthma.
Topics: Animals; Asthma; Bronchi; Cell Line; Cytokines; Disease Models, Animal; Epithelial Cells; Humans; Inflammasomes; Inflammation; Male; Mice; Mice, Inbred BALB C; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Respiratory Hypersensitivity; Toluene 2,4-Diisocyanate | 2020 |
Innate lymphoid cells in isocyanate-induced asthma: role of microRNA-155.
Topics: Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Immunity, Innate; Lymphocytes; Mice; Mice, Inbred C57BL; MicroRNAs; Toluene 2,4-Diisocyanate | 2020 |
Protective effects of N-acetylcysteine on a chemical-induced murine model of asthma.
Topics: Acetylcysteine; Allergens; Animals; Anti-Asthmatic Agents; Antioxidants; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; Glutathione; Immunoglobulin E; Interleukin-4; Interleukin-5; Leukocyte Count; Lung; Male; Mice, Inbred BALB C; Neutrophils; Superoxide Dismutase; Toluene 2,4-Diisocyanate | 2021 |
Activation of aryl hydrocarbon receptor by benzo[a]pyrene increases interleukin 33 expression and eosinophil infiltration in a mouse model of allergic airway inflammation.
Topics: A549 Cells; Animals; Basic Helix-Loop-Helix Transcription Factors; Benzo(a)pyrene; Chemotaxis, Leukocyte; Disease Models, Animal; Eosinophils; Female; Humans; Interleukin-33; Interleukin-8; Lung; Mice, Inbred BALB C; Pneumonia; Receptors, Aryl Hydrocarbon; Signal Transduction; Toluene 2,4-Diisocyanate; Up-Regulation | 2020 |
Acute and subacute oral administration of mycotoxin deoxynivalenol exacerbates the pro-inflammatory and pro-pruritic responses in a mouse model of allergic dermatitis.
Topics: Administration, Oral; Animals; Cytokines; Dendritic Cells; Dermatitis, Allergic Contact; Disease Models, Animal; Female; Humans; Inflammation Mediators; Keratinocytes; Mice, Inbred BALB C; Pruritus; Skin; Th2 Cells; THP-1 Cells; Toluene 2,4-Diisocyanate; Trichothecenes | 2020 |
The AKT inhibitor MK2206 suppresses airway inflammation and the pro‑remodeling pathway in a TDI‑induced asthma mouse model.
Topics: Airway Remodeling; Animals; Anti-Inflammatory Agents; Asthma; Cytokines; Dexamethasone; Disease Models, Animal; Heterocyclic Compounds, 3-Ring; Immunoglobulin E; Inflammation; Male; Mice; Mice, Inbred BALB C; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Toluene 2,4-Diisocyanate; Treatment Outcome | 2020 |
JNK modulates RAGE/β-catenin signaling and is essential for allergic airway inflammation in asthma.
Topics: Adult; Aged; Animals; Anti-Asthmatic Agents; Asthma; beta Catenin; Bronchoconstriction; Case-Control Studies; Cell Line; Disease Models, Animal; Female; Humans; JNK Mitogen-Activated Protein Kinases; Lung; Male; Mice, Inbred C57BL; Middle Aged; Phosphorylation; Pneumonia; Protein Kinase Inhibitors; Receptor for Advanced Glycation End Products; Serum Albumin, Human; Signal Transduction; Toluene 2,4-Diisocyanate | 2021 |
Anti-DLL4 ameliorates toluene diisocyanate-induced experimental asthma by inhibiting Th17 response.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antibodies; Asthma; Calcium-Binding Proteins; Disease Models, Animal; Female; Immunoglobulin E; Lung; Mice, Inbred BALB C; Spleen; Th17 Cells; Toluene 2,4-Diisocyanate | 2021 |
Distinct roles of PI3Kδ and PI3Kγ in a toluene diisocyanate-induced murine asthma model.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Class I Phosphatidylinositol 3-Kinases; Class Ib Phosphatidylinositol 3-Kinase; Disease Models, Animal; Eosinophils; Inflammation; Macrophages; Male; Mice; Mice, Inbred BALB C; Neutrophils; Toluene 2,4-Diisocyanate | 2021 |
Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma.
Topics: Animals; Antibodies, Monoclonal, Humanized; Asthma; Disease Models, Animal; Drug Resistance; Humans; Interleukin-6; Mice; Mice, Inbred BALB C; Respiratory Hypersensitivity; Signal Transduction; Toluene 2,4-Diisocyanate | 2022 |
Short Thymic Stromal Lymphopoietin Attenuates Toluene Diisocyanate-induced Airway Inflammation and Inhibits High Mobility Group Box 1-Receptor for Advanced Glycation End Products and Long Thymic Stromal Lymphopoietin Expression.
Topics: Animals; Asthma; Cell Line; Cytokines; Disease Models, Animal; Gene Expression; Glycation End Products, Advanced; HMGB1 Protein; Humans; Male; Mice, Inbred BALB C; Peptides; Phosphorylation; Protein Conformation; Receptor for Advanced Glycation End Products; STAT5 Transcription Factor; Thymic Stromal Lymphopoietin; Toluene 2,4-Diisocyanate | 2017 |
IL-13 is a central mediator of chemical-induced airway hyperreactivity in mice.
Topics: Animals; Antibodies; Asthma; Disease Models, Animal; Immunoglobulin E; Interleukin-13; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Toluene 2,4-Diisocyanate | 2017 |
A novel mouse model of atopic dermatitis that is T helper 2 (Th2)-polarized by an epicutaneous allergen.
Topics: Allergens; Animals; Dermatitis, Atopic; Detergents; Dinitrochlorobenzene; Disease Models, Animal; Female; Formaldehyde; Immunoglobulin E; Interferon-gamma; Interleukin-4; Isocyanates; Mast Cells; Mice, Inbred BALB C; Phthalic Anhydrides; Pyroglyphidae; Skin; Th2 Cells; Toluene; Toluene 2,4-Diisocyanate | 2018 |
Phosphorylation of low density lipoprotein receptor-related protein 6 is involved in receptor for advanced glycation end product-mediated β-catenin stabilization in a toluene diisocyanate-induced asthma model.
Topics: Animals; Asthma; beta Catenin; Bronchoalveolar Lavage Fluid; Cell Count; Cell Line; Disease Models, Animal; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; Low Density Lipoprotein Receptor-Related Protein-6; Lung; Male; Mice, Inbred BALB C; Phosphorylation; Receptor for Advanced Glycation End Products; Toluene 2,4-Diisocyanate | 2018 |
Oral Administration of Bisphenol A Directly Exacerbates Allergic Airway Inflammation but Not Allergic Skin Inflammation in Mice.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Cell Line; Cytokines; Dermatitis, Allergic Contact; Disease Models, Animal; Disease Progression; Environmental Pollutants; Epithelial Cells; Female; Humans; Inflammation; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Phenols; Respiratory Hypersensitivity; Toluene 2,4-Diisocyanate | 2018 |
Andrographolide prevented toluene diisocyanate-induced occupational asthma and aberrant airway E-cadherin distribution via p38 MAPK-dependent Nrf2 induction.
Topics: Animals; Anti-Asthmatic Agents; Asthma, Occupational; Bronchoalveolar Lavage Fluid; Cadherins; Collagen; Disease Models, Animal; Diterpenes; Female; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Respiratory Hypersensitivity; Toluene 2,4-Diisocyanate | 2018 |
RAGE mediates β-catenin stabilization via activation of the Src/p-Cav-1 axis in a chemical-induced asthma model.
Topics: Animals; Asthma; beta Catenin; Caveolin 1; Disease Models, Animal; Male; Mice, Inbred BALB C; Protein Stability; Receptor for Advanced Glycation End Products; Signal Transduction; src-Family Kinases; Toluene 2,4-Diisocyanate | 2018 |
IL-17F, rather than IL-17A, underlies airway inflammation in a steroid-insensitive toluene diisocyanate-induced asthma model.
Topics: Animals; Asthma; Bronchodilator Agents; Disease Models, Animal; Drug Resistance; Fluticasone; Glucocorticoids; Interleukin-17; Mice; Mice, Inbred BALB C; Prednisone; Toluene 2,4-Diisocyanate | 2019 |
Blockade of the NLRP3/Caspase-1 Axis Ameliorates Airway Neutrophilic Inflammation in a Toluene Diisocyanate-Induced Murine Asthma Model.
Topics: Airway Remodeling; Animals; Asthma; Caspase 1; Disease Models, Animal; Furans; Heterocyclic Compounds, 4 or More Rings; Indenes; Interleukin-18; Male; Mice; Mice, Inbred C57BL; Neutrophils; NLR Family, Pyrin Domain-Containing 3 Protein; Respiratory Hypersensitivity; Serpins; Sulfonamides; Sulfones; Th17 Cells; Th2 Cells; Toluene 2,4-Diisocyanate; Viral Proteins | 2019 |
Dermal exposure determines the outcome of repeated airway exposure in a long-term chemical-induced asthma-like mouse model.
Topics: Administration, Cutaneous; Administration, Intranasal; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Dendritic Cells; Disease Models, Animal; Immunoglobulin E; Immunoglobulin G; Leukocytes; Lung; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Toluene 2,4-Diisocyanate | 2019 |
Mechanism of E-cadherin redistribution in bronchial airway epithelial cells in a TDI-induced asthma model.
Topics: Allergens; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Cadherins; Cells, Cultured; Dexamethasone; Disease Models, Animal; Drug Antagonism; Epithelial Cells; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neutrophils; Toluene 2,4-Diisocyanate | 2013 |
Rat models of acute lung injury: exhaled nitric oxide as a sensitive, noninvasive real-time biomarker of prognosis and efficacy of intervention.
Topics: Acute Lung Injury; Animals; Asthma; Biomarkers; Breath Tests; Carbon Dioxide; Chlorine; Disease Models, Animal; Equipment Design; Exhalation; Inhalation Exposure; Lipopolysaccharides; Male; Nitric Oxide; Phosgene; Plethysmography, Impedance; Rats; Rats, Inbred BN; Rats, Wistar; Toluene 2,4-Diisocyanate | 2013 |
B-lymphocytes as key players in chemical-induced asthma.
Topics: Animals; Asthma; B-Lymphocyte Subsets; B7-1 Antigen; B7-2 Antigen; Bronchoconstrictor Agents; CD40 Antigens; Disease Models, Animal; Immunoglobulin E; Male; Methacholine Chloride; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, SCID; Toluene 2,4-Diisocyanate | 2013 |
Ethyl pyruvate decreases airway neutrophil infiltration partly through a high mobility group box 1-dependent mechanism in a chemical-induced murine asthma model.
Topics: Animals; Asthma; Cell Count; Cell Movement; Cells, Cultured; Chemokine CXCL2; Disease Models, Animal; HMGB1 Protein; Lung; Male; Mice; Neutrophils; Pyruvates; Receptors, Interleukin-8B; Toluene 2,4-Diisocyanate; Tumor Necrosis Factor-alpha | 2014 |
Phosphatidylinositol 3-kinases pathway mediates lung caspase-1 activation and high mobility group box 1 production in a toluene-diisocyanate induced murine asthma model.
Topics: Administration, Inhalation; Airway Resistance; Animals; Asthma; Carrier Proteins; Caspase 1; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; HMGB1 Protein; Inflammasomes; Lung; Male; Mice, Inbred BALB C; Neutrophil Infiltration; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Protein Transport; Random Allocation; Respiratory Mucosa; Signal Transduction; Specific Pathogen-Free Organisms; Toluene 2,4-Diisocyanate | 2015 |
Evaluation of anti-asthmatic and antioxidant potential of Boerhavia procumbens in toluene diisocyanate (TDI) treated rats.
Topics: Animals; Anti-Asthmatic Agents; Antioxidants; Asthma; Disease Models, Animal; Dose-Response Relationship, Drug; Hydrogen Peroxide; Male; Nyctaginaceae; Plant Extracts; Rats; Rats, Sprague-Dawley; Toluene 2,4-Diisocyanate | 2015 |
Aggression behaviour induced by oral administration of the Janus-kinase inhibitor tofacitinib, but not oclacitinib, under stressful conditions.
Topics: Administration, Oral; Aggression; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Behavior, Animal; Brain; Dermatitis, Atopic; Disease Models, Animal; Female; Janus Kinases; Male; Mice, Inbred BALB C; Piperidines; Protein Kinase Inhibitors; Pruritus; Pyrimidines; Pyrroles; Stress, Psychological; Sulfonamides; Toluene 2,4-Diisocyanate | 2015 |
Chicken IgY facilitates allergic airway inflammation in a chemical-induced murine asthma model by potentiating IL-4 release.
Topics: Animals; Asthma; Chickens; Disease Models, Animal; HMGB1 Protein; Immunoglobulins; Interleukin-4; Male; Mice; Mice, Inbred BALB C; Neutrophils; Toluene 2,4-Diisocyanate | 2015 |
Toluene diisocyanate and methylene diphenyl diisocyanate: asthmatic response and cross-reactivity in a mouse model.
Topics: Air Pollutants, Occupational; Animals; Asthma; Cross Reactions; Disease Models, Animal; Immunoglobulin E; Isocyanates; Male; Mice, Inbred C57BL; Th1-Th2 Balance; Toluene 2,4-Diisocyanate | 2016 |
A novel benzofuran, 4-methoxybenzofuran-5-carboxamide, from Tephrosia purpurea suppressed histamine H1 receptor gene expression through a protein kinase C-δ-dependent signaling pathway.
Topics: Animals; Anti-Allergic Agents; Benzofurans; Cytokines; Disease Models, Animal; Gene Expression Regulation; HeLa Cells; Histamine; Humans; Male; Protein Kinase C-delta; Rats; Rats, Inbred Strains; Receptors, Histamine H1; Rhinitis, Allergic; Tephrosia; Th2 Cells; Toluene 2,4-Diisocyanate | 2016 |
A Role for Regulatory T Cells in a Murine Model of Epicutaneous Toluene Diisocyanate Sensitization.
Topics: Animals; Antigens, CD; Cell Proliferation; Cells, Cultured; CTLA-4 Antigen; Dermatitis, Allergic Contact; Disease Models, Animal; Female; Inducible T-Cell Co-Stimulator Protein; Integrin alpha Chains; Kinetics; Lymphocyte Activation; Mice, Inbred BALB C; Neuropilin-1; Phenotype; Receptors, CCR6; Skin; T-Lymphocytes, Regulatory; Toluene 2,4-Diisocyanate | 2016 |
Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo.
Topics: Animals; Chemokine CCL17; Chemotaxis; Coculture Techniques; Dendritic Cells; Dermatitis, Atopic; Disease Models, Animal; Female; Histamine; Humans; Indoles; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Mice, Knockout; Ovalbumin; Piperazines; Pyrimidines; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Skin; Toluene 2,4-Diisocyanate | 2016 |
The receptor for advanced glycation end products is required for β-catenin stabilization in a chemical-induced asthma model.
Topics: Animals; Asthma; beta Catenin; Disease Models, Animal; Dose-Response Relationship, Drug; Glycation End Products, Advanced; Male; Mice; Mice, Inbred BALB C; Receptor for Advanced Glycation End Products; Structure-Activity Relationship; Toluene 2,4-Diisocyanate | 2016 |
Blockade of β-catenin signaling attenuates toluene diisocyanate-induced experimental asthma.
Topics: Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; beta Catenin; Biomarkers; Bridged Bicyclo Compounds, Heterocyclic; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Immunoglobulin E; Immunohistochemistry; Lymphocytes; Male; Mice; Molecular Targeted Therapy; Pyrimidinones; Signal Transduction; Toluene 2,4-Diisocyanate | 2017 |
Xinqin exhibits the anti-allergic effect through the JAK2/STAT5 signaling pathway.
Topics: Animals; Anti-Allergic Agents; Calcimycin; Cell Degranulation; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drugs, Chinese Herbal; Guinea Pigs; Histamine; Humans; Immunoglobulin E; Interleukin-6; Janus Kinase 2; Leukotriene D4; Male; Mast Cells; Phosphorylation; Rhinitis, Allergic; Signal Transduction; STAT5 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Tetradecanoylphorbol Acetate; Toluene 2,4-Diisocyanate; Tumor Necrosis Factor-alpha | 2016 |
Topically applied manganese-porphyrins BMX-001 and BMX-010 display a significant anti-inflammatory response in a mouse model of allergic dermatitis.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Cell Line; Dendritic Cells; Dermatitis, Allergic Contact; Disease Models, Animal; Ear; Female; Humans; Infant, Newborn; Inflammation; Interleukin-1beta; Interleukin-4; Keratinocytes; Metalloporphyrins; Mice; Mice, Inbred BALB C; p-Methoxy-N-methylphenethylamine; Pruritus; Skin; Skin Cream; Superoxide Dismutase; Toluene 2,4-Diisocyanate | 2016 |
Detection of low-level environmental chemical allergy by a long-term sensitization method.
Topics: Allergens; Animals; B-Lymphocytes; Cytokines; Dinitrochlorobenzene; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Immunization; Immunoglobulin E; Local Lymph Node Assay; Lymph Nodes; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred BALB C; Multiple Chemical Sensitivity; Phthalic Anhydrides; Toluene 2,4-Diisocyanate | 2008 |
Use of long term dermal sensitization followed by intratracheal challenge method to identify low-dose chemical-induced respiratory allergic responses in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Dermatitis, Allergic Contact; Dinitrochlorobenzene; Disease Models, Animal; Dose-Response Relationship, Immunologic; Environmental Pollutants; Female; Immunoglobulin E; Lung; Mice; Mice, Inbred BALB C; Phthalic Anhydrides; Respiratory Hypersensitivity; Toluene 2,4-Diisocyanate; Trachea | 2008 |
Comparative studies of lymph node cell subpopulations and cytokine expression in murine model for testing the potentials of chemicals to induce respiratory sensitization.
Topics: Allergens; Animals; Bronchial Provocation Tests; Cytokines; Dinitrochlorobenzene; Disease Models, Animal; Inflammation; Interferon-gamma; Interleukin-4; Irritants; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Phthalic Anhydrides; Respiratory Hypersensitivity; RNA, Messenger; Toluene 2,4-Diisocyanate | 2008 |
Sho-seiryu-to suppresses histamine signaling at the transcriptional level in TDI-sensitized nasal allergy model rats.
Topics: Animals; Cytokines; Disease Models, Animal; Drugs, Chinese Herbal; Histamine; Histidine Decarboxylase; Hypersensitivity; Male; Medicine, Kampo; Nasal Mucosa; Rats; Rats, Inbred BN; Receptors, Histamine H1; RNA, Messenger; Signal Transduction; Toluene 2,4-Diisocyanate | 2009 |
Is toluene diamine a sensitizer and is there cross-reactivity between toluene diamine and toluene diisocyanate?
Topics: Animals; Antigens, CD; Asthma; Cells, Cultured; Cross Reactions; Cytokines; Disease Models, Animal; Immunoglobulins; Local Lymph Node Assay; Lymphocytes; Male; Methacholine Chloride; Mice; Mice, Inbred BALB C; Phenylenediamines; Statistics, Nonparametric; Toluene 2,4-Diisocyanate | 2009 |
Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma.
Topics: Administration, Intranasal; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchoconstrictor Agents; Cytokines; Disease Models, Animal; Eosinophils; Immunoglobulin E; Male; Methacholine Chloride; Mice; Mice, Inbred BALB C; Neutrophils; Respiratory Aspiration; Toluene 2,4-Diisocyanate; Up-Regulation | 2009 |
Efficacy of repeated pretreatment with olopatadine hydrochloride on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Topics: Administration, Intranasal; Animals; Anti-Allergic Agents; Dibenzoxepins; Disease Models, Animal; Drug Administration Schedule; Histamine H1 Antagonists, Non-Sedating; Male; Nerve Growth Factor; Olopatadine Hydrochloride; Rats; Rats, Inbred BN; Rhinitis, Allergic, Seasonal; Terfenadine; Toluene 2,4-Diisocyanate; Vascular Endothelial Growth Factor A | 2009 |
The putative lipid raft modulator miltefosine displays immunomodulatory action in T-cell dependent dermal inflammation models.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents; Arachidonic Acid; Disease Models, Animal; Ear; Female; Hypersensitivity; Immunologic Factors; Inflammation; Interleukins; Membrane Microdomains; Mice; Phosphorylcholine; Pruritus; Skin; T-Lymphocytes; Toluene 2,4-Diisocyanate | 2010 |
Lung exposure to nanoparticles modulates an asthmatic response in a mouse model.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; Gold; Immunoglobulin E; Lung; Macrophages; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Neutrophils; Pulmonary Edema; Titanium; Toluene 2,4-Diisocyanate | 2011 |
Proteome analysis of multiple compartments in a mouse model of chemical-induced asthma.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Inflammation; Mass Spectrometry; Methacholine Chloride; Mice; Neutrophils; Oxidative Stress; Proteome; Toluene 2,4-Diisocyanate | 2010 |
Successful transfer of chemical-induced asthma by adoptive transfer of low amounts of lymphocytes in a mouse model.
Topics: Adoptive Transfer; Animals; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstrictor Agents; Disease Models, Animal; Immunoglobulin E; Lymphocytes; Male; Methacholine Chloride; Mice; Mice, Inbred BALB C; Neutrophils; Time Factors; Toluene 2,4-Diisocyanate | 2011 |
Transcriptional microarray analysis reveals suppression of histamine signaling by Kujin alleviates allergic symptoms through down-regulation of FAT10 expression.
Topics: Animals; Disease Models, Animal; Down-Regulation; Histamine; Histamine H1 Antagonists; Humans; Hypersensitivity; Male; Microarray Analysis; Nasal Mucosa; Phytotherapy; Plant Extracts; Rats; Rats, Inbred Strains; Signal Transduction; Sophora; Toluene 2,4-Diisocyanate; Ubiquitins | 2011 |
Albizia lebbeck suppresses histamine signaling by the inhibition of histamine H1 receptor and histidine decarboxylase gene transcriptions.
Topics: Albizzia; Animals; Disease Models, Animal; HeLa Cells; Histamine; Histamine H1 Antagonists; Histidine Decarboxylase; Humans; Male; Plant Bark; Plant Extracts; Rats; Rats, Inbred BN; Real-Time Polymerase Chain Reaction; Receptors, Histamine H1; Rhinitis, Allergic, Perennial; Signal Transduction; Toluene 2,4-Diisocyanate; Transcription, Genetic | 2011 |
AMPK activation reduces vascular permeability and airway inflammation by regulating HIF/VEGFA pathway in a murine model of toluene diisocyanate-induced asthma.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Asthma; Basic Helix-Loop-Helix Transcription Factors; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cytokines; Disease Models, Animal; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Pneumonia; Reactive Oxygen Species; Ribonucleotides; Signal Transduction; Toluene 2,4-Diisocyanate; Vascular Endothelial Growth Factor A | 2012 |
Immunological determinants in a murine model of toluene diisocyanate-induced asthma.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Cytokines; Disease Models, Animal; Female; Inhalation Exposure; Leukocytes; Macrophages; Mice; Toluene 2,4-Diisocyanate | 2012 |
Quercetin inhibits transcriptional up-regulation of histamine H1 receptor via suppressing protein kinase C-δ/extracellular signal-regulated kinase/poly(ADP-ribose) polymerase-1 signaling pathway in HeLa cells.
Topics: Animals; Cytosol; Dermatitis, Contact; Disease Models, Animal; Golgi Apparatus; HeLa Cells; Histamine; Histamine H1 Antagonists; Humans; Male; Phorbol Esters; Poly(ADP-ribose) Polymerases; Protein Kinase C-delta; Protein Transport; Quercetin; Rats; Rats, Inbred Strains; Receptors, Histamine H1; Signal Transduction; Toluene 2,4-Diisocyanate; Up-Regulation | 2013 |
Effects of thermal degradation products from polyurethane foams based on toluene diisocyanate and diphenylmethane diisocyanate on isolated, perfused lung of guinea pig.
Topics: Aerosols; Air Pollutants, Occupational; Animals; Chemical Industry; Disease Models, Animal; Environmental Monitoring; Female; Guinea Pigs; Hot Temperature; Isocyanates; Lung; Male; Perfusion; Polyurethanes; Probability; Risk Assessment; Toluene 2,4-Diisocyanate | 2003 |
[Immunohistochemical and pathological study of capsaicin in the treatment of rabbit animal model with allergic rhinitis].
Topics: Administration, Intranasal; Animals; Capsaicin; Disease Models, Animal; Female; Immunohistochemistry; Male; Nasal Mucosa; Rabbits; Rhinitis, Allergic, Perennial; Toluene 2,4-Diisocyanate | 1999 |
Toluene diisocyanate exposure induces laryngo-tracheal eosinophilia, which can be ameliorated by supplementation with antioxidant vitamins in guinea pigs.
Topics: alpha-Tocopherol; Animals; Antioxidants; Ascorbic Acid; Disease Models, Animal; Guinea Pigs; Larynx; Male; Pulmonary Eosinophilia; Toluene 2,4-Diisocyanate; Trachea | 2003 |
Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice.
Topics: Administration, Intranasal; Animals; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstrictor Agents; Dermatitis, Allergic Contact; Disease Models, Animal; Immunoglobulin E; Male; Methacholine Chloride; Mice; Mice, Inbred BALB C; Occupational Exposure; Plethysmography, Whole Body; Respiratory Mechanics; Toluene 2,4-Diisocyanate | 2004 |
Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma.
Topics: Animals; Anti-Bacterial Agents; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Doxycycline; Female; Inflammation; Lung; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Ovalbumin; Protease Inhibitors; RNA, Messenger; Toluene 2,4-Diisocyanate | 2004 |
Glutathione-conjugated toluene diisocyanate causes airway inflammation in sensitised mice.
Topics: Airway Resistance; Animals; Bronchial Provocation Tests; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Inflammation; Lung; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Respiratory Hypersensitivity; Toluene 2,4-Diisocyanate | 2004 |
Effect of glucocorticoid on upregulation of histamine H1 receptor mRNA in nasal mucosa of rats sensitized by exposure to toluene diisocyanate.
Topics: Animals; Anti-Inflammatory Agents; Dexamethasone; Disease Models, Animal; Glucocorticoids; Male; Nasal Mucosa; Random Allocation; Rats; Receptors, Histamine H1; Reverse Transcriptase Polymerase Chain Reaction; Toluene 2,4-Diisocyanate; Up-Regulation | 2004 |
Delayed-type asthmatic response induced by repeated intratracheal exposure to toluene-2,4-diisocyanate in guinea pigs.
Topics: Airway Resistance; Albumins; Albuterol; Allergens; Animals; Asthma; Chromones; Dexamethasone; Disease Models, Animal; Fucose; Guinea Pigs; Hypersensitivity, Delayed; Immunoglobulin E; Immunoglobulin G; Male; Time Factors; Toluene 2,4-Diisocyanate; Trachea | 2005 |
Airway inflammatory and immunological events in a rat model exposed to toluene diisocyanate.
Topics: Administration, Inhalation; Allergens; Animals; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Eosinophils; Female; Inhalation Exposure; Rats; Rats, Wistar; Toluene 2,4-Diisocyanate | 2005 |
Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.
Topics: Animals; Antibody Formation; Antibody Specificity; Asthma; Disease Models, Animal; Female; Inflammation; Interleukin-1; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Interleukin-1; Respiratory Hypersensitivity; Signal Transduction; Toluene 2,4-Diisocyanate; Up-Regulation | 2005 |
TDI can induce respiratory allergy with Th2-dominated response in mice.
Topics: Administration, Topical; Animals; Bronchi; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Eosinophils; Female; Immunoglobulin E; Inhalation Exposure; Injections, Subcutaneous; Lung; Mice; Mice, Inbred BALB C; Respiratory Hypersensitivity; Th2 Cells; Toluene 2,4-Diisocyanate | 2006 |
Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Catechin; Disease Models, Animal; Gene Expression Regulation; Inflammation; Interleukin-5; Matrix Metalloproteinase 9; Mice; Reactive Oxygen Species; Respiratory System; Toluene 2,4-Diisocyanate; Tumor Necrosis Factor-alpha | 2006 |
Nasal congestion model in Brown Norway rats and the effects of some H1-antagonists.
Topics: Animals; Chlorpheniramine; Dibenzazepines; Disease Models, Animal; Histamine; Histamine H1 Antagonists; Imidazoles; Ketotifen; Male; Nasal Mucosa; Plethysmography, Whole Body; Rats; Rats, Inbred BN; Rhinitis; Toluene 2,4-Diisocyanate | 2006 |
Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate.
Topics: Airway Resistance; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Immunoglobulins; In Vitro Techniques; Lymphocytes; Male; Methacholine Chloride; Mice; Mice, Inbred BALB C; Mice, SCID; Skin; Toluene 2,4-Diisocyanate | 2007 |
Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma.
Topics: Animals; Asthma; Cell Adhesion Molecules; Cytokines; Disease Models, Animal; Inflammation; Mice; NF-kappa B; PPAR gamma; Respiratory System; Th2 Cells; Toluene 2,4-Diisocyanate; Transforming Growth Factor beta1 | 2006 |
Airway inflammation and bronchial remodelling in toluene diisocyanate-exposed BALB/c mouse model.
Topics: Alum Compounds; Animals; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Eosinophils; Female; Immunoglobulin E; Inflammation; Interleukin-4; Mice; Mice, Inbred BALB C; Neutrophils; Ovalbumin; Th2 Cells; Toluene 2,4-Diisocyanate | 2007 |
Inhalation of toluene diisocyanate vapor induces allergic rhinitis in mice.
Topics: Administration, Inhalation; Aerosols; Animals; Antibody Specificity; Cytokines; Disease Models, Animal; Female; Immunoglobulin E; Immunoglobulin G; Mice; Mice, Inbred C57BL; Nasal Mucosa; Occupational Diseases; Random Allocation; Rhinitis, Allergic, Perennial; Th1 Cells; Th2 Cells; Toluene 2,4-Diisocyanate | 2007 |
Maternal allergic contact dermatitis causes increased asthma risk in offspring.
Topics: Animals; Asthma; Dermatitis, Allergic Contact; Dinitrochlorobenzene; Disease Models, Animal; Disease Susceptibility; Female; Gene Expression Regulation; Interleukin-4; Irritants; Lung; Male; Maternal Exposure; Mice; Mice, Inbred BALB C; Pregnancy; Prenatal Exposure Delayed Effects; Risk Factors; Th1 Cells; Th2 Cells; Toluene 2,4-Diisocyanate | 2007 |
PTEN down-regulates IL-17 expression in a murine model of toluene diisocyanate-induced airway disease.
Topics: Adenoviridae; Animals; Asthma; Disease Models, Animal; Down-Regulation; Female; Inflammation; Inhalation Exposure; Interleukin-17; Mice; Mice, Inbred BALB C; NF-kappa B; Nitriles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; PTEN Phosphohydrolase; Sulfones; Toluene 2,4-Diisocyanate | 2007 |
Progress in allergy signal research on mast cells: up-regulation of histamine signal-related gene expression in allergy model rats.
Topics: Animals; Dexamethasone; Disease Models, Animal; Gene Expression Regulation; HeLa Cells; Histamine; Histidine Decarboxylase; Humans; Hypersensitivity; Male; Mast Cells; Nasal Mucosa; Rats; Rats, Inbred BN; Receptors, Histamine H1; Signal Transduction; Toluene 2,4-Diisocyanate; Up-Regulation | 2008 |
Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Topics: Animals; Anti-Allergic Agents; Dibenzoxepins; Disease Models, Animal; Histamine; Histamine H1 Antagonists, Non-Sedating; Male; Nasal Lavage Fluid; Nerve Growth Factor; Olopatadine Hydrochloride; Rats; Rats, Sprague-Dawley; Rhinitis, Allergic, Perennial; Toluene 2,4-Diisocyanate; Vascular Endothelial Growth Factor A | 2008 |
[Nasal allergy observed in an asthma model by toluene diisocyanate (TDI)].
Topics: Animals; Asthma; Cyanates; Disease Models, Animal; Guinea Pigs; Histamine Release; Rhinitis, Allergic, Perennial; Toluene 2,4-Diisocyanate | 1984 |
The guinea pig model of diisocyanate sensitization. I. Immunologic studies.
Topics: Animals; Asthma; Cross Reactions; Cyanates; Disease Models, Animal; Female; Guinea Pigs; Humans; Immunization; Immunodiffusion; Immunoelectrophoresis; Immunoglobulin E; Immunoglobulin G; Isocyanates; Occupational Diseases; Passive Cutaneous Anaphylaxis; Serum Albumin; Toluene 2,4-Diisocyanate; Transferrin | 1982 |
The guinea pig model of diisocyanate sensitization. II. Physiologic studies.
Topics: Animals; Asthma; Cyanates; Disease Models, Animal; Female; Guinea Pigs; Immune Sera; Immunoglobulin E; Isocyanates; Occupational Diseases; Respiratory Function Tests; Toluene 2,4-Diisocyanate; Transferrin | 1982 |
[On the induction of asthma in guinea pigs by toluene diisocyanate (TDI)].
Topics: Animals; Asthma; Cyanates; Disease Models, Animal; Guinea Pigs; Toluene 2,4-Diisocyanate | 1982 |
Experimental model of asthma by toluene diisocyanate (TDI).
Topics: Animals; Asthma; Cyanates; Disease Models, Animal; Female; Guinea Pigs; Lung; Male; Occupational Diseases; Toluene 2,4-Diisocyanate | 1983 |
A murine model for assessing the respiratory hypersensitivity potential of chemical allergens.
Topics: Administration, Intranasal; Administration, Topical; Allergens; Analysis of Variance; Animals; Cytokines; Dinitrochlorobenzene; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Haptens; Immunoglobulin E; Immunoglobulin G; Luminescent Measurements; Lung; Mice; Mice, Inbred BALB C; Respiratory Hypersensitivity; Skin; Toluene 2,4-Diisocyanate | 1995 |
Effects of topical capsaicin on autonomic nerves in experimentally-induced nasal hypersensitivity. An immunocytochemical study.
Topics: Administration, Intranasal; Animals; Autonomic Nervous System; Calcitonin Gene-Related Peptide; Capsaicin; Disease Models, Animal; Female; Guinea Pigs; Nasal Mucosa; Olfactory Bulb; Rhinitis, Allergic, Perennial; Substance P; Toluene 2,4-Diisocyanate; Tyrosine 3-Monooxygenase | 1993 |
An asthma model developed in the guinea pig by intranasal application of 2,4-toluene diisocyanate.
Topics: Administration, Intranasal; Animals; Asthma; Disease Models, Animal; Guinea Pigs; Histamine Release; Immunoglobulin E; Immunoglobulin G; Lung; Male; Passive Cutaneous Anaphylaxis; Respiration; Toluene 2,4-Diisocyanate | 1993 |
Experimental study on respiratory sensitivity to inhaled toluene diisocyanate.
Topics: Administration, Inhalation; Animals; Antibody Specificity; Disease Models, Animal; Female; Guinea Pigs; Histamine Release; Immunoglobulin G; Lung; Mast Cells; Prostaglandins E; Respiratory Hypersensitivity; Serum Albumin; Toluene 2,4-Diisocyanate | 1993 |
A two-centre study for the evaluation and validation of an animal model for the assessment of the potential of small molecular weight chemicals to cause respiratory allergy.
Topics: Administration, Inhalation; Allergens; Animals; Antibody Specificity; Antigen-Antibody Complex; Dinitrochlorobenzene; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Haptens; Injections, Intradermal; Isocyanates; Male; Molecular Weight; Phthalic Anhydrides; Respiration; Respiratory Hypersensitivity; Serum Albumin; Toluene 2,4-Diisocyanate | 1995 |
[Airway inflammatory cell dynamics during late asthmatic reactions induced by toluene diisocyanate in guinea pigs. I. Bronchoalveolar lavage study].
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; Guinea Pigs; Hypersensitivity, Delayed; Inflammation; Male; Respiratory System; Toluene 2,4-Diisocyanate | 1993 |
[Toluene 2,4-diisocyanate induced late asthmatic response and dual asthmatic response in guinea pigs].
Topics: Animals; Asthma; Disease Models, Animal; Guinea Pigs; Hypersensitivity, Delayed; Immunoglobulin E; Immunoglobulin G; Male; Passive Cutaneous Anaphylaxis; Toluene 2,4-Diisocyanate | 1993 |
[Experimental models of nasal hypersensitive reaction].
Topics: Animals; Disease Models, Animal; Guinea Pigs; Hypersensitivity, Immediate; Nasal Mucosa; Rhinitis, Allergic, Perennial; Toluene 2,4-Diisocyanate | 1993 |
Toluene diisocyanate induction of airway hyperresponsiveness at the threshold limit value (10 ppb) in rabbits.
Topics: Acetylcholine; Airway Resistance; Animals; Blood Pressure; Bronchial Hyperreactivity; Bronchial Provocation Tests; Disease Models, Animal; Elasticity; Lung Diseases; Maximum Allowable Concentration; Occupational Diseases; Rabbits; Reproducibility of Results; Toluene 2,4-Diisocyanate | 1995 |
Role of substance P and neurokinin A in toluene diisocyanate-induced increased airway responsiveness in rabbits.
Topics: Acetylcholine; Administration, Inhalation; Airway Resistance; Animals; Bronchi; Bronchoconstriction; Capsaicin; Disease Models, Animal; Lung Diseases; Muscle, Smooth; Neurokinin A; Neurokinin-1 Receptor Antagonists; Occupational Diseases; Rabbits; Receptors, Neurokinin-2; Substance P; Toluene 2,4-Diisocyanate; Trachea | 1996 |
Assessment of respiratory hypersensitivity in guinea pigs sensitized to toluene diisocyanate: improvements on analysis of respiratory response.
Topics: Administration, Inhalation; Allergens; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Guinea Pigs; Hypersensitivity, Delayed; Injections, Intradermal; Mathematics; Reproducibility of Results; Respiration; Respiratory Hypersensitivity; Time Factors; Toluene 2,4-Diisocyanate | 1997 |
Immunization and challenge with toluene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways.
Topics: Animals; Bronchial Provocation Tests; Calcitonin Gene-Related Peptide; Cell Count; Disease Models, Animal; Eosinophils; Guinea Pigs; Immunization; Immunoglobulin G; Immunohistochemistry; Inflammation; Male; Nerve Fibers; Respiratory System; Substance P; Tachykinins; Toluene 2,4-Diisocyanate | 1998 |
Subchronic exposure to diisocyanates increases guinea pig tracheal smooth muscle responses to acetylcholine.
Topics: Acetylcholine; Animals; Culture Techniques; Cyanates; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Guinea Pigs; Isocyanates; Lung Diseases; Muscle Contraction; Muscle, Smooth; Reference Values; Toluene 2,4-Diisocyanate; Trachea | 1999 |
Effect of dietary vitamin E supplementation on murine nasal allergy.
Topics: Allergens; Animals; Cytokines; Dietary Supplements; Disease Models, Animal; Drug Hypersensitivity; Female; Immunoglobulin E; Interferon-gamma; Interleukins; Lymphocyte Count; Mice; Mice, Inbred BALB C; Random Allocation; Spleen; Toluene 2,4-Diisocyanate; Vitamin E | 1999 |
Effects of the phosphodiesterase 4 inhibitor RPR 73401 in a model of immunological inflammation.
Topics: Administration, Topical; Animals; Benzamides; Cyclosporine; Dermatitis, Allergic Contact; Dinitrobenzenes; Disease Models, Animal; Female; Interleukin-4; Mice; Mice, Inbred BALB C; Phosphodiesterase Inhibitors; Pyridines; Toluene 2,4-Diisocyanate | 2000 |
Modification of serum proteins in guinea pigs immunized and challenged with toluene diisocyanate.
Topics: Animals; Antibodies; Blotting, Western; Disease Models, Animal; Electrophoresis, Gel, Pulsed-Field; Enzyme-Linked Immunosorbent Assay; Guinea Pigs; Hypersensitivity, Immediate; Immunoproteins; Injections, Intradermal; Male; Sensitivity and Specificity; Toluene 2,4-Diisocyanate | 2000 |
Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI).
Topics: Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Disease Models, Animal; Female; Inflammation Mediators; Mice; Mice, Inbred C57BL; Mice, Nude; Toluene 2,4-Diisocyanate | 2001 |
A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Female; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Protease Inhibitors; Toluene 2,4-Diisocyanate | 2001 |
Elevated interleukin-4 and interleukin-6 in rats sensitized with toluene diisocyanate.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Interleukin-4; Interleukin-6; Lung; Lymphocyte Subsets; Lymphocytes; Male; Occupational Diseases; Rats; Rats, Wistar; Spleen; Statistics, Nonparametric; Toluene 2,4-Diisocyanate | 2001 |
Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.
Topics: Administration, Inhalation; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cell Migration Inhibition; Cell Movement; Disease Models, Animal; Endothelial Growth Factors; Extravasation of Diagnostic and Therapeutic Materials; Female; Indoles; Inflammation; Leukocyte Count; Lymphokines; Mice; Mice, Inbred BALB C; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Toluene 2,4-Diisocyanate; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Comparison of clinical and experimental data from an animal model of pulmonary immunologic sensitivity.
Topics: Allergens; Animals; Antigen-Antibody Reactions; Atmosphere Exposure Chambers; Cyanates; Disease Models, Animal; Equipment Design; Guinea Pigs; Lung Diseases; Respiratory Hypersensitivity; Toluene 2,4-Diisocyanate | 1991 |
[An experimental etiological study of toluene diisocyanate (TDI) induced occupational asthma].
Topics: Animals; Asthma; Disease Models, Animal; Guinea Pigs; Immunoglobulin E; Occupational Diseases; Passive Cutaneous Anaphylaxis; Toluene 2,4-Diisocyanate | 1991 |
Contact sensitivity induced in mice by methylene bisphenyl diisocyanate.
Topics: Administration, Cutaneous; Animals; Cross Reactions; Cyanates; Dermatitis, Contact; Disease Models, Animal; Hypersensitivity, Delayed; Immunization, Passive; Isocyanates; Male; Mice; Mice, Inbred C57BL; T-Lymphocytes; Toluene 2,4-Diisocyanate | 1987 |
A nasal allergy model developed in the guinea pig by intranasal application of 2,4-toluene diisocyanate.
Topics: Administration, Intranasal; Animals; Cyanates; Disease Models, Animal; Guinea Pigs; Histamine; Male; Mucus; Nasal Mucosa; Passive Cutaneous Anaphylaxis; Rhinitis, Allergic, Perennial; Toluene 2,4-Diisocyanate | 1988 |
[Additional findings on contact sensitivity of mice induced by toluene diisocyanate (TDI)].
Topics: Animals; Cyanates; Dermatitis, Contact; Disease Models, Animal; Female; Fluocinolone Acetonide; Mice; Toluene 2,4-Diisocyanate | 1985 |
[A case report on death due to an asthmatic attack observed in a guinea pig with TDI-induced asthma].
Topics: Animals; Asthma; Cyanates; Disease Models, Animal; Guinea Pigs; Lung; Male; Nasal Mucosa; Toluene 2,4-Diisocyanate | 1986 |